infectious diseases

Why Merck is in infectious disease for the long haul
Why Merck is in infectious disease for the long haul
BioCentury
Merck
R&D
infectious diseases
antibiotics
Flag link:
5 things to know about Hookipa Pharma ahead of its IPO
5 things to know about Hookipa Pharma ahead of its IPO
Marketwatch
Hookipa
IPOs
cancer
infectious diseases
Flag link:
Hookipa proposes IPO as its cancer vaccines head towards the clinic
Hookipa proposes IPO as its cancer vaccines head towards the clinic
BioCentury
Hookipa
IPOs
vaccines
cancer
infectious diseases
Flag link:
Researchers point to R&D treaty to spur new infectious disease treatments
Researchers point to R&D treaty to spur new infectious disease treatments
Endpoints
R&D
infectious diseases
Flag link:
ContraFect Corporation Prices $10 Million Public Offering of Common Stock to Develop Novel Infectious Disease Treatments
ContraFect Corporation Prices $10 Million Public Offering of Common Stock to Develop Novel Infectious Disease Treatments
CP Wire
ContraFect
infectious diseases
Flag link:
Evotec seals deal for Sanofi’s infectious disease unit
Evotec seals deal for Sanofi’s infectious disease unit
Fierce Biotech
Evotec
Sanofi
M&A
infectious diseases
Flag link:
Allergan plans sales of women's health, infectious disease units
Allergan plans sales of women's health, infectious disease units
Reuters
Allergan
M&A
Women's Health
infectious diseases
Flag link:
Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ID Week 2016
Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ID Week 2016
Yahoo
Merck
Zostavax
vaccines
infectious diseases
Zerbaxa
Flag link:
A New Index Measures Impact Pharma Has on Infectious Diseases
A New Index Measures Impact Pharma Has on Infectious Diseases
WSJ/Pharmalot
infectious diseases
Flag link:
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Pharmaceutical Business Review
Riboxx
Riboxxim
China National Biotech Group
infectious diseases
Flag link:
ABC News Reports on Aethlon Medical
ABC News Reports on Aethlon Medical
Aethlon Medical
Hemopurifier
cancer
infectious diseases
Flag link:
FDA Clears Single-Use Antibacterial Surgical Respirator
FDA Clears Single-Use Antibacterial Surgical Respirator
FDA
surgical respirator
SpectraShield
infectious diseases
approvals
Flag link:
Aethlon Medical Discloses Part II of Emerging Opportunities in Biodefense Interview
Aethlon Medical Discloses Part II of Emerging Opportunities in Biodefense Interview
Aethlon Medical
Aethlon Hemopurifier
infectious diseases
cancer
Flag link:
Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
Aethlon Medical
Aethlon Hemopurifier
India
infectious diseases
oncology
Flag link:
Baxter Creates New Medical Products Business and Announces Key Leadership Changes
Baxter Creates New Medical Products Business and Announces Key Leadership Changes
Baxter International
hemophilia
immune disorders
infectious diseases
kidney disease
trauma
Flag link:
Affordable Mass Screening to Curb Pandemics Now Possible with MicroKit IBN’s All-in-One Device Detects Infectious Diseases Rapidly and Accurately
Affordable Mass Screening to Curb Pandemics Now Possible with MicroKit IBN’s All-in-One Device Detects Infectious Diseases Rapidly and Accurately
Institute of Bioengineering and Nanotechnology
MicroKit
infectious diseases
Flag link:
Cempra Pharmaceuticals Presents New Data on TAKSTA(TM) (CEM-102, sodium fusidate) at the 50th IntersConference on Antimicrobial Agents and Chemotherapy (ICAAC)
Cempra Pharmaceuticals Presents New Data on TAKSTA(TM) (CEM-102, sodium fusidate) at the 50th IntersConference on Antimicrobial Agents and Chemotherapy (ICAAC)
PR-USA.net
Cempra
infectious diseases
MRSA
Taksta
Flag link:
Nearly 400 Medicines And Vaccines In Development To Fight Infectious Diseases
Nearly 400 Medicines And Vaccines In Development To Fight Infectious Diseases
Medical News Today
infectious diseases
Flag link:
Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
Aethlon Medical
infectious diseases
Flag link:
Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
Yahoo/PR NewsWire
Peregrine Pharmaceuticals
infectious diseases
Flag link: